Verastem Quarterly Balance Sheets Chart
Quarterly
|
Annual
Verastem Quarterly Balance Sheets Table
Quarterly
|
Annual
Unit: USD | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||||||||||||||||||
current assets: | |||||||||||||||||||||||||||||||||||
cash and cash equivalents | 94,986,000 | 183,086,000 | 97,260,000 | 74,933,000 | 78,166,000 | 63,950,000 | 46,687,000 | 21,252,000 | 24,314,000 | 24,972,000 | 35,514,000 | 67,782,000 | 170,470,000 | 125,328,000 | 135,061,000 | 43,514,000 | 103,320,000 | 113,080,000 | 91,525,000 | 129,867,000 | 130,727,000 | 168,692,000 | 64,215,000 | 82,176,000 | 51,270,000 | 27,583,000 | 28,179,000 | 32,349,000 | 37,274,000 | 39,564,000 | 15,147,000 | 24,870,000 | 19,831,000 | 35,172,000 | 30,125,000 |
short-term investments | 70,677,000 | 13,944,000 | 12,961,000 | 25,810,000 | 30,357,000 | 59,591,000 | 79,004,000 | 79,102,000 | 83,163,000 | 85,583,000 | 73,444,000 | 31,992,000 | 56,908,000 | 74,173,000 | 120,134,000 | 119,786,000 | 14,912,000 | 4,496,000 | 8,994,000 | 30,335,000 | 44,392,000 | 48,548,000 | 49,608,000 | 53,302,000 | 84,388,000 | 85,388,000 | 100,636,000 | 96,921,000 | 101,946,000 | ||||||
accounts receivable | 3,326,000 | 2,524,000 | 2,203,000 | 1,389,000 | 558,000 | 306,000 | 10,562,000 | ||||||||||||||||||||||||||||
prepaid expenses and other current assets | 8,822,000 | 6,875,000 | 7,689,000 | 4,945,000 | 4,709,000 | 3,437,000 | 4,517,000 | 4,968,000 | 5,236,000 | 6,149,000 | 5,456,000 | 3,473,000 | 3,033,000 | 6,558,000 | 5,887,000 | 3,835,000 | 4,049,000 | 3,410,000 | 4,073,000 | 2,973,000 | 2,397,000 | 1,745,000 | 1,815,000 | 1,115,000 | 940,000 | 1,835,000 | 1,434,000 | 398,000 | 431,000 | 667,000 | 1,002,000 | 585,000 | 714,000 | 651,000 | 2,801,000 |
total current assets | 174,485,000 | 189,963,000 | 118,893,000 | 92,870,000 | 108,759,000 | 97,875,000 | 113,439,000 | 105,740,000 | 108,757,000 | 114,760,000 | 127,678,000 | 144,938,000 | 188,555,000 | 144,592,000 | 148,646,000 | 84,961,000 | 166,958,000 | 192,346,000 | 216,596,000 | 253,259,000 | 158,729,000 | 170,437,000 | 66,030,000 | 87,787,000 | 61,204,000 | 59,753,000 | 74,005,000 | 81,295,000 | 87,313,000 | 93,533,000 | 100,537,000 | 110,843,000 | 121,181,000 | 132,744,000 | 134,872,000 |
property and equipment | 35,000 | 40,000 | 62,000 | 92,000 | 121,000 | 151,000 | 180,000 | 210,000 | 240,000 | 270,000 | 335,000 | 416,000 | 497,000 | 791,000 | 866,000 | 947,000 | 1,041,000 | 1,149,000 | 1,256,000 | 1,369,000 | 1,210,000 | 1,270,000 | 1,003,000 | 861,000 | 989,000 | 1,127,000 | 1,271,000 | 1,417,000 | 1,569,000 | 1,728,000 | 1,865,000 | 2,048,000 | 2,282,000 | 2,456,000 | 2,645,000 |
right-of-use asset | 2,995,000 | 3,077,000 | 3,146,000 | 3,225,000 | 3,303,000 | ||||||||||||||||||||||||||||||
restricted cash | 35,241,000 | 35,241,000 | 242,000 | 242,000 | 403,000 | 162,000 | 162,000 | 162,000 | 162,000 | 162,000 | 162,000 | 162,000 | 162,000 | 203,000 | 203,000 | 203,000 | 203,000 | ||||||||||||||||||
other assets | 56,000 | 20,000 | 36,000 | 58,000 | 47,000 | 84,000 | 105,000 | 169,000 | 223,000 | 103,000 | 21,000 | 33,000 | 23,000 | 401,000 | 790,000 | 812,000 | 1,055,000 | 1,028,000 | 1,025,000 | 1,031,000 | 1,005,000 | 969,000 | 975,000 | 981,000 | 784,000 | 797,000 | 811,000 | 755,000 | 293,000 | 282,000 | |||||
total assets | 176,153,000 | 191,758,000 | 120,877,000 | 95,050,000 | 111,095,000 | 100,409,000 | 116,148,000 | 108,662,000 | 111,877,000 | 123,890,000 | 136,901,000 | 154,349,000 | 217,770,000 | 198,532,000 | 208,154,000 | 145,046,000 | 192,600,000 | 218,541,000 | 243,365,000 | 277,236,000 | 183,155,000 | 172,918,000 | 68,411,000 | 89,791,000 | 63,139,000 | 61,839,000 | 76,249,000 | 83,629,000 | 89,044,000 | 95,423,000 | 102,564,000 | 113,094,000 | 123,666,000 | 135,696,000 | 142,003,000 |
liabilities, convertible preferred stock and stockholders’ equity | |||||||||||||||||||||||||||||||||||
current liabilities: | |||||||||||||||||||||||||||||||||||
accounts payable | 5,118,000 | 4,553,000 | 4,903,000 | 4,901,000 | 5,359,000 | 1,706,000 | 2,896,000 | 2,302,000 | 641,000 | 1,395,000 | 2,453,000 | 1,875,000 | 4,681,000 | 2,241,000 | 7,233,000 | 9,655,000 | 8,842,000 | 11,538,000 | 8,593,000 | 10,253,000 | 11,249,000 | 8,514,000 | 7,267,000 | 9,186,000 | 7,363,000 | 6,825,000 | 8,809,000 | 4,095,000 | 1,962,000 | 2,149,000 | 2,595,000 | 3,942,000 | 3,646,000 | 2,999,000 | 3,951,000 |
accrued expenses | 13,756,000 | 13,938,000 | 14,983,000 | 14,788,000 | 17,658,000 | 13,294,000 | 15,621,000 | 12,257,000 | 10,739,000 | 8,808,000 | 14,660,000 | 23,164,000 | 21,449,000 | 18,010,000 | 19,365,000 | 21,289,000 | 19,372,000 | 19,828,000 | 21,108,000 | 38,664,000 | 12,234,000 | 7,578,000 | 7,942,000 | 12,255,000 | 4,241,000 | 4,424,000 | 6,896,000 | 4,258,000 | 3,776,000 | 3,529,000 | 6,098,000 | 7,171,000 | 6,478,000 | 5,254,000 | |
note payable | |||||||||||||||||||||||||||||||||||
deferred liabilities | |||||||||||||||||||||||||||||||||||
lease liability, short-term | 902,000 | 865,000 | 829,000 | 794,000 | 761,000 | 728,000 | 696,000 | 667,000 | 638,000 | 610,000 | 583,000 | 558,000 | 533,000 | 508,000 | 485,000 | 420,000 | 379,000 | 294,000 | 203,000 | ||||||||||||||||
convertible senior notes | 19,938,000 | 68,556,000 | 101,249,000 | 99,163,000 | 97,159,000 | 95,231,000 | |||||||||||||||||||||||||||||
total current liabilities | 23,812,000 | 20,787,000 | 22,359,000 | 21,663,000 | 21,873,000 | 20,092,000 | 16,886,000 | 18,590,000 | 13,536,000 | 12,744,000 | 11,844,000 | 17,093,000 | 37,678,000 | 28,784,000 | 25,728,000 | 29,890,000 | 30,510,000 | 31,204,000 | 28,624,000 | 37,077,000 | 53,441,000 | 22,132,000 | 14,845,000 | 17,128,000 | 19,618,000 | 11,066,000 | 13,233,000 | 10,991,000 | 6,220,000 | 5,925,000 | 6,124,000 | 10,109,000 | 10,864,000 | 9,837,000 | 9,461,000 |
non-current liabilities: | |||||||||||||||||||||||||||||||||||
long-term debt | 35,276,000 | 35,067,000 | 34,882,000 | 34,673,000 | 24,814,000 | 19,506,000 | 21,535,000 | 23,520,000 | 14,913,000 | 14,828,000 | 2,335,000 | 2,293,000 | 2,249,000 | ||||||||||||||||||||||
lease liability, long-term | 3,359,000 | 3,489,000 | 3,572,000 | 3,694,000 | 3,808,000 | ||||||||||||||||||||||||||||||
other long-term liabilities | |||||||||||||||||||||||||||||||||||
preferred stock tranche liability | |||||||||||||||||||||||||||||||||||
total liabilities | 71,814,000 | 69,008,000 | 66,693,000 | 47,659,000 | 48,222,000 | 46,517,000 | 43,377,000 | 21,103,000 | 16,222,000 | 35,685,000 | 34,292,000 | 39,075,000 | 87,997,000 | 84,159,000 | 85,171,000 | 137,872,000 | 171,083,000 | 169,234,000 | 154,905,000 | 152,937,000 | 75,542,000 | 46,051,000 | 29,859,000 | 32,107,000 | 22,154,000 | 13,607,000 | 15,777,000 | ||||||||
convertible preferred stock: | |||||||||||||||||||||||||||||||||||
series b convertible preferred stock, 0.0001 par value; 2,144 and 0 shares designated at september 30, 2023 and december 31, 2022, respectively; 1,200 and 0 shares issued and outstanding at september 30, 2023 and december 31, 2022, respectively | |||||||||||||||||||||||||||||||||||
stockholders’ equity: | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized: | |||||||||||||||||||||||||||||||||||
series a convertible preferred stock, 0.0001 par value; 1,000 shares designated, 1,000 shares issued and outstanding at september 30, 2023 and december 31, 2022 | |||||||||||||||||||||||||||||||||||
common stock | 3,000 | 3,000 | 20,000 | 20,000 | 21,000 | 19,000 | 19,000 | 19,000 | 18,000 | 17,000 | 17,000 | 17,000 | 17,000 | 17,000 | 16,000 | 8,000 | 7,000 | 7,000 | 7,000 | 7,000 | 7,000 | 7,000 | 5,000 | 5,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 |
additional paid-in capital | 880,650,000 | 879,105,000 | 786,236,000 | 784,894,000 | 783,606,000 | 756,628,000 | 753,538,000 | 751,217,000 | 742,840,000 | 712,593,000 | 710,100,000 | 707,715,000 | 702,403,000 | 700,141,000 | 685,733,000 | 531,937,000 | 507,494,000 | 505,086,000 | 502,021,000 | 499,741,000 | 471,831,000 | 469,415,000 | 362,739,000 | 360,823,000 | 325,886,000 | 310,014,000 | 308,801,000 | 307,587,000 | 306,040,000 | 304,733,000 | 303,006,000 | 301,305,000 | 299,215,000 | 296,800,000 | 288,060,000 |
accumulated other comprehensive income | 49,000 | 1,000 | 6,000 | 34,000 | 27,000 | 39,000 | 34,000 | 53,000 | 9,000 | 14,000 | 27,000 | 86,000 | 110,000 | 127,000 | 2,000 | 4,000 | 2,000 | 12,000 | 29,000 | 60,000 | 77,000 | 135,000 | 43,000 | 44,000 | 32,000 | 39,000 | |||||||||
accumulated deficit | -562,775,000 | -524,785,000 | -486,011,000 | -455,872,000 | -413,678,000 | -375,576,000 | -364,227,000 | -342,559,000 | -324,192,000 | -303,142,000 | -284,907,000 | -261,781,000 | -248,345,000 | -235,323,000 | -223,668,000 | -215,746,000 | -207,177,000 | -198,883,000 | |||||||||||||||||
total stockholders’ equity | 83,180,000 | 101,591,000 | 33,025,000 | 47,391,000 | 62,873,000 | 53,892,000 | 72,771,000 | 87,559,000 | 95,655,000 | 88,205,000 | 102,609,000 | 115,274,000 | 129,773,000 | 114,373,000 | 122,983,000 | 7,174,000 | 21,517,000 | 49,307,000 | 88,460,000 | 124,299,000 | 107,613,000 | 126,867,000 | 38,552,000 | 57,684,000 | 40,985,000 | 48,232,000 | 60,472,000 | 72,297,000 | 82,436,000 | 89,068,000 | 95,968,000 | 102,469,000 | 112,243,000 | 125,261,000 | 131,905,000 |
total liabilities, convertible preferred stock and stockholders’ equity | 176,153,000 | 191,758,000 | 120,877,000 | ||||||||||||||||||||||||||||||||
series b convertible preferred stock, 0.0001 par value; 2,144 and 0 shares designated at june 30, 2023 and december 31, 2022, respectively; 1,200 and 0 shares issued and outstanding at june 30, 2023 and december 31, 2022, respectively | |||||||||||||||||||||||||||||||||||
series a convertible preferred stock, 0.0001 par value; 1,000 shares designated, 1,000 shares issued and outstanding at june 30, 2023 and december 31, 2022 | |||||||||||||||||||||||||||||||||||
series b convertible preferred stock, 0.0001 par value; 2,144 and 0 shares designated at march 31, 2023 and december 31, 2022, respectively; 1,200 and 0 shares issued and outstanding at march 31, 2023 and december 31, 2022, respectively | |||||||||||||||||||||||||||||||||||
series a convertible preferred stock, 0.0001 par value; 1,000 shares designated, 1,000 shares issued and outstanding at march 31, 2023 and december 31, 2022 | |||||||||||||||||||||||||||||||||||
liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, 1,000 and 0 shares issued and outstanding at december 31, 2022 and december 31, 2021, respectively | |||||||||||||||||||||||||||||||||||
accumulated other comprehensive income/ | -39,000 | -130,000 | -113,000 | ||||||||||||||||||||||||||||||||
total liabilities and stockholders’ equity | 95,050,000 | 111,095,000 | 100,409,000 | 116,148,000 | 108,662,000 | 111,877,000 | 123,890,000 | 136,901,000 | 154,349,000 | 217,770,000 | 198,532,000 | 208,154,000 | 145,046,000 | 192,600,000 | 218,541,000 | 243,365,000 | 277,236,000 | 183,155,000 | 172,918,000 | 68,411,000 | 89,791,000 | 63,139,000 | 61,839,000 | 76,249,000 | 83,629,000 | 89,044,000 | 95,423,000 | 102,564,000 | 113,094,000 | 123,666,000 | 135,696,000 | 142,003,000 | |||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at september 30, 2022 and december 31, 2021, respectively | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at june 30, 2022 and december 31, 2021, respectively | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at march 31, 2022 and december 31, 2021, respectively | |||||||||||||||||||||||||||||||||||
long-term investments | 4,001,000 | ||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at december 31, 2021 and december 31, 2020, respectively | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at september 30, 2021 and december 31, 2020, respectively | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at june 30, 2021 and december 31, 2020, respectively | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at march 31, 2021 and december 31, 2020, respectively | |||||||||||||||||||||||||||||||||||
inventory | 4,372,000 | 3,096,000 | 478,000 | 294,000 | 306,000 | 327,000 | 131,000 | ||||||||||||||||||||||||||||
intangible assets | 19,616,000 | 20,008,000 | 20,400,000 | 20,793,000 | 21,185,000 | 21,577,000 | 21,969,000 | ||||||||||||||||||||||||||||
derivative liability, short-term | 450,000 | ||||||||||||||||||||||||||||||||||
other non-current liabilities | 870,000 | 870,000 | 870,000 | 500,000 | 500,000 | 1,123,000 | 566,000 | 399,000 | 101,000 | 151,000 | 201,000 | 248,000 | 295,000 | ||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at december 31, 2020 and december 31, 2019, respectively | |||||||||||||||||||||||||||||||||||
current portion of long-term debt | 5,716,000 | 3,528,000 | 1,384,000 | ||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at september 30, 2020 and december 31, 2019, respectively | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at june 30, 2020 and december 31, 2019, respectively | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at march 31, 2020 and december 31, 2019, respectively | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at december 31, 2019 and december 31, 2018, respectively | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at september 30, 2019 and december 31, 2018, respectively | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at june 30, 2019 and december 31, 2018, respectively | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at march 31, 2019 and december 31, 2018, respectively | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at december 31, 2018 and december 31, 2017, respectively | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at september 30, 2018 and december 31, 2017, respectively | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at june 30, 2018 and december 31, 2017, respectively | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at march 31, 2018 and december 31, 2017, respectively | |||||||||||||||||||||||||||||||||||
accumulated other comprehensive loss | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at december 31, 2017 and 2016, respectively | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at september 30, 2017 and december 31, 2016, respectively | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at june 30, 2017 and december 31, 2016, respectively | |||||||||||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at march 31, 2017 and december 31, 2016, respectively | |||||||||||||||||||||||||||||||||||
liability classified stock-based compensation awards | 69,000 | 47,000 | 360,000 | 256,000 | |||||||||||||||||||||||||||||||
other liabilities | 341,000 | 388,000 | 430,000 | 472,000 | 516,000 | 559,000 | 598,000 | 637,000 | |||||||||||||||||||||||||||
preferred stock, 0.0001 par value; 5,000 shares authorized, no shares issued and outstanding at december 31, 2016 and 2015, respectively | |||||||||||||||||||||||||||||||||||
convertible preferred stock | |||||||||||||||||||||||||||||||||||
deficit accumulated during the development stage | |||||||||||||||||||||||||||||||||||
liability for shares subject to repurchase |
We provide you with 20 years of balance sheets for Verastem stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Verastem. Explore the full financial landscape of Verastem stock with our expertly curated balance sheets.
The information provided in this report about Verastem stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.